Clinical Trials Logo

Female Pattern Hair Loss clinical trials

View clinical trials related to Female Pattern Hair Loss.

Filter by:
  • None
  • Page 1

NCT ID: NCT06440655 Recruiting - Clinical trials for Platelet-Rich Plasma

The Efficacy and Safety of Platelet-rich Fibrin and Platelet Rich Plasma in Female Pattern Hair Loss Patients

PRF
Start date: May 30, 2023
Phase: N/A
Study type: Interventional

The goal of this clinical trial is to compare between platelet-rich fibrin and platelet-rich plasma in female pattern hair loss . The main question[s] it aims to answer are: - efficacy between platelet-rich fibrin and platelet-rich plasma - safety between platelet-rich fibrin and platelet-rich plasma Participants will be divided into 2 side of treatment with composed of 1. Platelet rich plasma 2. Platelet rich fibrin

NCT ID: NCT04090801 Completed - Clinical trials for Female Pattern Hair Loss

Comparison of Topical Minoxidil 5% in Ethanol Plus Propylene Glycol Versus Minoxidil 5% in Ethanol Alone in Treatment of Women With Female Pattern Hair Loss

FPHL
Start date: May 30, 2015
Phase: Phase 4
Study type: Interventional

The study will be included 60 women with FPHL. The diagnosis of FPHL will be established by clinical (Ludwig classification) and trichoscopic evaluation of frontal and occipital regions of the scalp.

NCT ID: NCT02486848 Withdrawn - Clinical trials for Androgenetic Alopecia

Minoxidil Dose Response Study in Females Identified Through IVD Testing as Non-Responders to 5% Topical Minoxidil

Start date: June 2016
Phase: N/A
Study type: Interventional

5% topical minoxidil is the maximum dosage approved by the US FDA for the treatment of female pattern hair loss. While topical minoxidil exhibits a good safety profile, the efficacy in the overall population is relatively low i.e., 30-40% re-grow hair. The primary purpose of this study is to assess if a higher dosage of topical minoxidil dosage (15%) will increase the number of responders among female subjects that have been identified through IVD testing as non-responders to 5% topical minoxidil.

NCT ID: NCT02206802 Completed - Alopecia Clinical Trials

Minoxidil Response Testing in Females With Female Pattern Hair Loss

Start date: July 2014
Phase:
Study type: Observational

The primary purpose of this study is to evaluate the clinical validity of the minoxidil response in-vitro diagnostic kit.

NCT ID: NCT01900041 Completed - Clinical trials for Female Pattern Hair Loss

A Study to Evaluate the Superiority, Efficacy and Tolerability of Combination Pantovigar With 2% Minoxidil vs 2% Minoxidil in Women With Female Pattern Hair Loss

Start date: April 2012
Phase: Phase 2
Study type: Interventional

Pantovigar - a high effective product designed primarily for the treatment of diffuse hair loss in women as well as for the treatment of damaged hair, in the combined therapy can be successfully applied in other types of alopecia. The purpose of this study is to evaluate efficacy and tolerability of combination therapy Pantovigar plus 2% minoxidil vs 2% minoxidil. To collect tolerability data for combined treatment Pantovigar plus 2% Minoxidil course therapy.

NCT ID: NCT00958750 Completed - Clinical trials for Androgenetic Alopecia

Efficacy and Safety Study to Compare Two Minoxidil Formulations on Women With Androgenetic Alopecia

Start date: June 2008
Phase: Phase 3
Study type: Interventional

The purpose of this study is to determine in women the risk/benefit profile and non-inferiority of a topical 5% Minoxidil foam formulation applied once daily for the treatment of androgenetic alopecia in comparison to 2% MTS used twice daily, using objective and subjective efficacy measures and safety assessments for a study period of 24 weeks.

NCT ID: NCT00175617 Completed - Clinical trials for Female Pattern Hair Loss

Efficacy of Therapy With the Spironolactone Pills Compared to Minoxidil Lotion in Female Pattern Hair Loss

Start date: September 2005
Phase: Phase 2
Study type: Interventional

This study evaluates the efficacy of therapy with the anti-androgen spironolactone compared to topical minoxidil in female pattern hair loss.